Global Rotator Cuff Reinforcement Device Market Research Report 2022

Tendon reinforcement devices have been used extensively to treat severe rotator cuff ruptures but are limited by the increasing trend of the arthroscopic technique used for shoulder repair, which makes it difficult to overlay the reinforcement mesh. The total rotator cuff reinforcement market consists of allograft, xenograft and alloplast reinforcement devices. Market growth will be sustained as the number of procedures involving rotator cuff repair continues to grow, of which a constant percentage will be more severe and require additional augmentation on top of suture anchoring, increasing the demand for reinforcement products. The growth is expected to increase over the next few years as more surgeons become capable of using the reinforcement devices in arthroscopic procedures.
Due to the COVID-19 pandemic, the global Rotator Cuff Reinforcement Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Rotator Cuff Reinforcement Device market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Rotator Cuff Reinforcement Device landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
As demand increases for rotator cuff reinforcement devices as a result of the rising number of shoulder repair procedures performed on elderly patients, strong growth will continue to be observed in the market. The allograft segment was the largest of the three rotator cuff reinforcement device segments. Despite being more expensive, the exceptional performance and longstanding clinical history of allografts make them preferable to both xenograft and synthetic devices. The allograft segment saw more units sold at a higher ASP than the xenograft and alloplast segments.
This report focuses on Rotator Cuff Reinforcement Device volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Rotator Cuff Reinforcement Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Rotator Cuff Reinforcement Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Allograft Reinforcement Devices
Xenograft Reinforcement Devices
Alloplast Reinforcement Devices
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Arthrex
Smith and Nephew
MicroPort
Allosource
Artelon
Biomet
Conmed Linvatec
Integra LifeSciences
RTI Biologics
Stryker
Synthasome
Tissue Regenix
Tornier
Wright Medical
Zimmer